Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

@article{Marzano2001PreventionOH,
  title={Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.},
  author={Alfredo Marzano and Mauro Salizzoni and Wilma Debernardi-Venon and Antonella Smedile and Alessandro Franchello and Alessia Ciancio and Elena Gentilcore and Paolo Piantino and Anna Maria Barbui and Ezio David and Francesco Negro and Mario Rizzetto},
  journal={Journal of hepatology},
  year={2001},
  volume={34 6},
  pages={
          903-10
        }
}

• Alfredo Marzano, Mauro Salizzoni, +9 authors Mario Rizzetto
• Published in Journal of hepatology 2001
• DOI:10.1016/S0168-8278(01)00080-0

BACKGROUND/AIMS Treatment with hepatitis B virus immune globulins (HBIG) or lamivudine has reduced the rate of hepatitis B recurrence after liver transplantation to approximately 50%. METHODS To further decrease hepatitis B recurrence, 33 hepatitis B virus (HBV)-related cirrhotic patients were treated with lamivudine before liver transplantation and with lamivudine together with low-dose HBIG (46 500 IU the first month followed by 5,000 lU/monthly) after surgery. RESULTS While on lamivudine… CONTINUE READING

View on PubMed

Alternate Sources

Save to Library

Create Alert

Cite